The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Self-citationMoore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072252 · Cited by 2,517
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Chemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
Van Cutsem, E., Köhne, C.-H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5091 · Cited by 1,882
Douillard, J.-Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4860 · Cited by 1,809
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
(1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.896 · Cited by 1,189
Role of poly(ADP-ribose) formation in DNA repair
Satoh, M. S., & Lindahl, T. (1992) · Nature · doi:10.1038/356356a0 · Cited by 1,174
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.301 · Cited by 981
Cassidy, J., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T.-S., Rivera, F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9898 · Cited by 862
Fuchs, C. S., Marshall, J., Mitchell, E., Wierzbicki, R., Ganju, V., Jeffery, M., Schulz, J., Richards, D., Soufi-Mahjoubi, R., Wang, B., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3357 · Cited by 851
Salonga, D. S., Danenberg, K. D., Johnson, M. R., Metzger, R., Groshen, S. G., Tsao-Wei, D. D., Lenz, H.-J., Leichman, C. G., Leichman, L., Diasio, R. B., et al. (2000) · PubMed · Cited by 829
Self-citationCunningham, D., Chau, I., Stocken, D. D., Valle, J. W., Smith, D., Steward, W., Harper, P. G., Dunn, J., Tudur-Smith, C., West, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2446 · Cited by 823
Johnston, P. G., Lenz, H.-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., & Leichman, L. (1995) · PubMed · Cited by 672
Self-citationSargent, D., Sobrero, A., Grothey, A., O'Connell, M. J., Buyse, M., Andre, T., Zheng, Y., Green, E., Labianca, R., O'Callaghan, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.5362 · Cited by 666
Paz-Ares, L. G., de Marinis, F., Dediu, M., Thomas, M., Pujol, J.-L., Bidoli, P., Molinier, O., Sahoo, T. P., Laack, E., Reck, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.1102 · Cited by 624
DNA Glycosylases, Endonucleases for Apurinic/Apyrimidinic Sites, and Base Excision-Repair
Lindahl, T. (1979) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60800-4 · Cited by 554
Sch�ller, J., Cassidy, J., Dumont, E., Roos, B., Banken, L., Mori, K., Reigner, B., Utoh, M., Weidekamm, E., & Durston, S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050043 · Cited by 534
Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic Sarcoma
Jaffe, N., Frei, E., Traggis, D., & Bishop, Y. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411072911902 · Cited by 483
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.
Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., & Allegra, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8977 · Cited by 382
Benjamin, R. C., & Gill, D. M. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70490-6 · Cited by 376
Poly(ADP-ribose) levels in carcinogen-treated cells
Juarez-Salinas, H., Sims, J. L., & Jacobson, M. K. (1979) · Nature · doi:10.1038/282740a0 · Cited by 348
Shirasaka, T., Shimamoto, Y., & Fukushima, M. (1993) · PubMed · Cited by 348
Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
Sobrero, A. F., Aschele, C., & Bertino, J. R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.368 · Cited by 336
Yoshino, T., Mizunuma, N., Yamazaki, K., Nishina, T., Komatsu, Y., Baba, H., Tsuji, A., Yamaguchi, K., Muro, K., Sugimoto, N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70345-5 · Cited by 326
Ishikawa, T., Utoh, M., Sawada, N., Nishida, M., Fukase, Y., Sekiguchi, F., & Ishitsuka, H. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00682-5 · Cited by 325
Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy
Niyikiza, C., Baker, S. D., Seitz, D. E., Walling, J. M., Nelson, K., Rusthoven, J. J., Stabler, S. P., Paoletti, P., Calvert, A. H., & Allen, R. H. (2002) · PubMed · doi:10.25405/ncl.34649535 · Cited by 268
Taylor, E. C., Kuhnt, D., Shih, C., Rinzel, S. M., Grindey, G. B., Barredo, J., Jannatipour, M., & Moran, R. G. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00101a023 · Cited by 254
Yamada, Y., Takahari, D., Matsumoto, H., Baba, H., Nakamura, M., Yoshida, K., Yoshida, M., Iwamoto, S., Shimada, K., Komatsu, Y., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70490-x · Cited by 248
Wang, D., Luo, M., & Kelley, M. R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.679.3.6 · Cited by 240
Jones, T. R., Calvert, A. H., Jackman, A. L., Brown, S. J., Jones, M., & Harrap, K. R. (1981) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(81)90206-1 · Cited by 238
Fuchs, C. S., Marshall, J., & Barrueco, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5390 · Cited by 217
Cocconi, G., Cunningham, D., Van Cutsem, E., Francois, E., Gustavsson, B., van Hazel, G., Kerr, D., Possinger, K., & Hietschold, S. M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2943 · Cited by 216
Inhibition of Dihydrofolic Reductase by Aminopterin and Amethopterin.
Osborn, M. J., Freeman, M., & Huennekens, F. M. (1958) · Experimental Biology and Medicine · doi:10.3181/00379727-97-23764 · Cited by 216
Muro, K., Boku, N., Shimada, Y., Tsuji, A., Sameshima, S., Baba, H., Satoh, T., Denda, T., Ina, K., Nishina, T., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70181-9 · Cited by 215
Pemetrexed Disodium: A Novel Antifolate Clinically Active Against Multiple Solid Tumors
Hanauske, A.-R., Chen, V., Paoletti, P., & Niyikiza, C. (2001) · The Oncologist · doi:10.1634/theoncologist.6-4-363 · Cited by 210
Pritchard, D. M., Watson, A. J. M., Potten, C. S., Jackman, A. L., & Hickman, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1795 · Cited by 198
REYES, P., & HEIDELBERGER, C. (1965) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14702-0 · Cited by 198
Rutman, R. J., CANTAROW, A., & Paschkis, K. E. (1954) · PubMed · Cited by 196
Peters, G. J., van der Wilt, C. L., van Groeningen, C. J., Smid, K., Meijer, S., & Pinedo, H. M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2035 · Cited by 196
Houghton, J. A., Maroda, S. J., Phillips, J. O., & Houghton, P. J. (1981) · PubMed · Cited by 194
Therapy of Choriocarcinoma and Related Trophoblastic Tumors with Folic Acid and Purine Antagonists
Li, M. C., Hertz, R., & Bergenstal, D. M. (1958) · New England Journal of Medicine · doi:10.1056/nejm195807102590204 · Cited by 189
Thymidylate synthase as an oncogene
Rahman, L., Voeller, D., Rahman, M., Lipkowitz, S., Allegra, C., Barrett, J. C., Kaye, F. J., & Zajac-Kaye, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00080-7 · Cited by 178
Thymidylate synthase inhibitors as anticancer agents: from bench to bedside
Chu, E., Callender, M. A., Farrell, M. P., & Schmitz, J. C. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0625-9 · Cited by 174
Chu, E., & Allegra, C. J. (1993) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-2488-5_16 · Cited by 166
Silber, J. R., Bobola, M. S., Blank, A., Schoeler, K. D., Haroldson, P. D., Huynh, M. B., & Kolstoe, D. D. (2002) · PubMed · Cited by 163
Takechi, T., Nakano, K., Uchida, J., Mita, A., Toko, K., Takeda, S., Unemi, N., & Shirasaka, T. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050561 · Cited by 162
Liu, L., Taverna, P., Whitacre, C. M., Chatterjee, S., & Gerson, S. L. (1999) · PubMed · Cited by 162
Asbestos and the lung in the 21st century: an update
Prazakova, S., Thomas, P. S., Sandrini, A., & Yates, D. H. (2014) · The Clinical Respiratory Journal · doi:10.1111/crj.12028 · Cited by 161
Purification and characterization of an apurinic/apyrimidinic endonuclease from HeLa cells.
Kane, C. M., & Linn, S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69623-7 · Cited by 160
Righi, L., Papotti, M. G., Ceppi, P., Billè, A., Bacillo, E., Molinaro, L., Ruffini, E., Scagliotti, G. V., & Selvaggi, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9275 · Cited by 160
Folate-based thymidylate synthase inhibitors as anticancer drugs
Jackman, A. L., & Calvert, A. H. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059353 · Cited by 160
Luo, M., & Kelley, M. R. (2004) · PubMed · Cited by 145
Houghton, J. A., Houghton, P. J., & Wooten, R. S. (1979) · PubMed · Cited by 142
Chemistry and biology of pteridines and folates
Lecocq, A. (1994) · Biochimie · doi:10.1016/0300-9084(94)90133-3 · Cited by 140
Advances in the systemic therapy of malignant pleural mesothelioma
Fennell, D. A., Gaudino, G., O'Byrne, K. J., Mutti, L., & van Meerbeeck, J. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1039 · Cited by 136
Sun, J., Han, J., Ahn, J. S., Park, K., & Ahn, M. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182208ea8 · Cited by 132
FDA Drug Approval Summaries: Pemetrexed (Alimta®)
Hazarika, M., White, R. M., Johnson, J. R., & Pazdur, R. (2004) · The Oncologist · doi:10.1634/theoncologist.9-5-482 · Cited by 132
Zhao, R., Qiu, A., Tsai, E., Jansen, M., Akabas, M. H., & Goldman, I. D. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045443 · Cited by 129
Emura, T., Suzuki, N., Yamaguchi, M., Ohshimo, H., & Fukushima, M. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.3.571 · Cited by 120
Regulation of p53 expression by thymidylate synthase
Ju, J., Pedersen-Lane, J., Maley, F., & Chu, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3769 · Cited by 117
Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1
Simeonov, A. M., Kulkarni, A., Dorjsuren, D. G., Jadhav, A., Shen, M., McNeill, D. R., Austin, C. P., & Wilson, D. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005740 · Cited by 112
Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514.
Schultz, R. M., Patel, V. F., Worzalla, J. F., & Shih, C. (1999) · PubMed · Cited by 111
Ladner, R. D., Lynch, F. J., Groshen, S. G., Xiong, Y., Sherrod, A., Caradonna, S. J., Stoehlmacher, J., & Lenz, H. (2000) · PubMed · Cited by 107
Self-citationGlazer, R. I., & Lloyd, L. S. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14632-4 · Cited by 106
Zucali, P. A., Giovannetti, E., Destro, A., Mencoboni, M., Ceresoli, G. L., Gianoncelli, L., Lorenzi, E., Vincenzo, F. D., Simonelli, M., Perrino, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2873 · Cited by 103
Jackman, A. L., Kèlland, L. R., Kimbell, R., Brown, M., Gibson, W. H., Aherne, G. W., Hardcastle, A., & Boyle, F. T. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.178 · Cited by 102
Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours
Doi, T., Ohtsu, A., Yoshino, T., Boku, N., Onozawa, Y., Fukutomi, A., Hironaka, S., Koizumi, W., & Sasaki, T. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.274 · Cited by 102
S-1: a promising new oral fluoropyrimidine derivative
Saif, M. W., Syrigos, K. N., & Katirtzoglou, N. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902729412 · Cited by 101
Pemetrexed Indirectly Activates the Metabolic Kinase AMPK in Human Carcinomas
Rothbart, S. B., Racanelli, A. C., & Moran, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1873 · Cited by 98
Qiu, L., Tang, Q., Bai, J., Qian, X., Li, R., Liu, B., & Zheng, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23822 · Cited by 97
Rosa, S., Fortini, P., Karran, P., Bignami, M., & Dogliotti, E. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5569 · Cited by 97
Caradonna, S. J., & Cheng, Y.-C. (1980) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14548-3 · Cited by 96
Pemetrexed disodium, a novel antifolate with multiple targets
Curtin, N. J., & Hughes, A. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00325-9 · Cited by 94
Bulgar, A., Weeks, L. D., Miao, Y., Yang, S., Xu, Y., Guo, C., Markowitz, S. D., Oleinick, N. L., Gerson, S. L., & Liu, L. (2012) · Cell Death and Disease · doi:10.1038/cddis.2011.135 · Cited by 94
Schultz, R. M., Vj, C., Bewley, J. R., Roberts, E. F., Shih, C., & Dempsey, J. A. (1999) · PubMed · Cited by 93
Caradonna, S. J., & Cheng, Y. (1980) · PubMed · Cited by 93
Bijnsdorp, I. V., Peters, G. J., Temmink, O. H., Fukushima, M., & Kruyt, F. A. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24943 · Cited by 92
Cassidy, J., Saltz, L., Twelves, C., Van Cutsem, E., Hoff, P., Kang, Y., Saini, J. P., Gilberg, F., & Cunningham, D. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr031 · Cited by 90
Christoph, D. C., Asuncion, B. R., Hassan, B., Tran, C., Maltzman, J. D., O'Shannessy, D. J., Wynes, M. W., Gauler, T. C., Wohlschlaeger, J., Hoiczyk, M., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827628ff · Cited by 89
Zhao, R. C., Babani, S., Gao, F., Liu, L., & Goldman, I. D. (2000) · PubMed · Cited by 89
Koehler, S. E., & Ladner, R. D. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05645-1 · Cited by 82
Self-citationFazzone, W., Wilson, P. M., LaBonte, M. J., Lenz, H., & Ladner, R. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24403 · Cited by 80
Self-citationLigand-mediated Induction of Thymidylate Synthase Occurs by Enzyme Stabilization
Kitchens, M. E., Forsthoefel, A. M., Rafique, Z., Spencer, H. T., & Berger, F. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12544 · Cited by 79
Canman, C. E., Lawrence, T. S., Shewach, D. S., Tang, H.-Y. Y., & Maybaum, J. (1993) · PubMed · Cited by 77
McNeill, D. R., Lam, W., DeWeese, T. L., Cheng, Y.-C., & Wilson, D. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0519 · Cited by 76
Bottomley, A., Gaafa, R., Manegold, C., Burgers, S. J. A., Coens, C., Legrand, C., Vincent, M. D., Giaccone, G., & van Meerbeeck, J. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3027 · Cited by 73
Wang, Y., Zhao, R., & Goldman, I. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0645 · Cited by 73
5-Fluorouracil substitution alters pre-mRNA splicing in vitro.
Doong, S.-L., & Dolnick, B. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68949-5 · Cited by 70
Molecular prescreening to select patient population in early clinical trials
Rodon, J. A., Saura, C., Dienstmann, R., Vivancos, A. P., y Cajal, S. R., Baselga, J. M., & Tabernero, J. M. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.48 · Cited by 68
Cohen, M. H., Justice, R. L., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0092 · Cited by 68
Asbestos and its lethal legacy
Tweedale, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc774 · Cited by 67
Fakih, M., Pendyala, L., Fetterly, G. J., Toth, K., Zwiebel, J. A., Espinoza‐Delgado, I., Litwin, A. M., Rustum, Y. M., Ross, M. E., Holleran, J. L., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2999 · Cited by 65
Longley, D. B., Ferguson, P., Boyer, J., Latif, T., Lynch, M., Maxwell, P., Harkin, D. P., & Johnston, P. G. (2001) · PubMed · Cited by 63
Self-citationMechanism of Thymineless Death
Goulian, M., Bleile, B., Dickey, L. M., Grafström, R. H., Ingraham, H. A., Neynaber, S. A., Peterson, M. S., & Tseng, B. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-1248-2_15 · Cited by 62
Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase
Danenberg, P. V., & Lockshin, A. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90068-1 · Cited by 62
Self-citationWilson, P. M., El-Khoueiry, A. B., Iqbal, S., Fazzone, W., LaBonte, M. J., Groshen, S. G., Yang, D., Danenberg, K. D., Cole, S., Kornacki, M., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1236-x · Cited by 61
Self-citationUracil–DNA Glycosylase Expression Determines Human Lung Cancer Cell Sensitivity to Pemetrexed
Weeks, L. D., Fu, P., & Gerson, S. L. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0172 · Cited by 61
Wilson, P. M., LaBonte, M. J., Lenz, H., Mack, P. C., & Ladner, R. D. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0781 · Cited by 60
Self-citationCohen, M. H., Cortazar, P., Justice, R. L., & Pazdur, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0224 · Cited by 56
Temmink, O. H., Hoebe, E. K., van der Born, K., Ackland, S. P., Fukushima, M., & Peters, G. J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603549 · Cited by 53
Novel opportunities for thymidylate metabolism as a therapeutic target
Wilson, P. M., Fazzone, W., LaBonte, M. J., Deng, J. N., Neamati, N., & Ladner, R. D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0280 · Cited by 53
Self-citationDecreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance
Humeniuk, R., Menon, L. G., Mishra, P. J., Gorlick, R., Sowers, R., Rode, W., Pizzorno, G., Cheng, Y.-C., Kemeny, N., Bertino, J. R., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0716 · Cited by 50
Huehls, A. M., Wagner, J. M., Huntoon, C. J., Geng, L., Erlichman, C., Patel, A. G., Kaufmann, S. H., & Karnitz, L. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0814 · Cited by 49
Small-Molecule Inhibitors of APE1 DNA Repair Function: An Overview
Al-Safi, R. I., Odde, S., Shabaik, Y., & Neamati, N. (2011) · Current Molecular Pharmacology · doi:10.2174/1874467211205010014 · Cited by 48
Mode of action of trifluorothymidine (TFT) against DNA replication and repair enzymes
Suzuki, N. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1003 · Cited by 47
Grimminger, P., Shi, M., Barrett, C. J., Lebwohl, D., Danenberg, K. D., Brabender, J., Vigen, C. L. P., Danenberg, P. V., Winder, T., & Lenz, H. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.29 · Cited by 43
Self-citationGeng, L., Huehls, A. M., Wagner, J. M., Huntoon, C. J., & Karnitz, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028862 · Cited by 40
Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy, F., Allegra, C. J., Sinha, B. K., & Grem, J. L. (1994) · PubMed · Cited by 40
Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaks
SUZUKI, N., Nakagawa, F., Nukatsuka, M., & Fukushima, M. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.244 · Cited by 39
Temmink, O. H., Hoebe, E. K., Fukushima, M., & Peters, G. J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.022 · Cited by 39
Matt, P., van Zwieten‐Boot, B., Calvo, G., ter Hofstede, H. J. M., García‐Carbonero, R., Camarero, J., Abadie, E., & Pignatti, F. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0224 · Cited by 38
Gordon, M. S., Rosen, L. S., Mendelson, D. S., Ramanathan, R. K., Goldman, J., Liu, L., Xu, Y., Gerson, S. L., Anthony, S. P., Figg, W. D., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9876-9 · Cited by 37
Miyahara, S., Miyakoshi, H., Yokogawa, T., Chong, K. T., Taguchi, J., Muto, T., Endoh, K., Yano, W., Wakasa, T., Ueno, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201628y · Cited by 34
Sun, J., Ahn, J. S., Park, K., Han, J., & Ahn, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.7579 · Cited by 34
Intracellular Thymidylate Synthase Inhibition by Trifluorothymidine in FM3A Cells
Temmink, O. H., Comijn, E. M., Fukushima, M., & Peters, G. J. (2004) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1081/ncn-200027707 · Cited by 33
Kato, T., Shimamoto, Y., Uchida, J., Ohshimo, H., Abe, M., Shirasaka, T., & Fukushima, M. (2001) · PubMed · Cited by 32
Saito, K., Nagashima, H., Noguchi, K., Yoshisue, K., Yokogawa, T., Matsushima, E., Tahara, T., & Shigeru, T. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2383-2 · Cited by 32
Maus, M. K. H., Mack, P. C., Astrow, S. H., Stephens, C. L., Zeger, G. D., Grimminger, P., Hsiang, J., Huang, E. C., Li, T., Lara, P. N., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318287c3c5 · Cited by 28
Rutman, R. J., CANTAROW, A., & Paschkis, K. E. (1954) · PubMed · Cited by 27
Saif, M. W. (2005) · Clinical Colorectal Cancer · doi:10.3816/ccc.2005.n.020 · Cited by 27
Bagrij, T., Kralovánszky, J., Gyergyay, F., Kiss, E., & Peters, G. J. (1993) · PubMed · Cited by 27
Raltitrexed: optimism and reality
Wilson, K. S., & Taylor, S. C. M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903307455 · Cited by 21
Involvement of base excision repair in response to therapy targeted at thymidylate synthase
Li, L., Berger, S. H., & Wyatt, M. D. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.747.3.6 · Cited by 20
Cited by
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Metabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Vodenkova, S., Buchler, T., Cervena, K., Veskrnova, V., Vodicka, P., & Vymetalkova, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107447 · Cited by 956
Pharmacologic resistance in colorectal cancer: a review
Hammond, W. A., Swaika, A., & Mody, K. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834015614530 · Cited by 519
Dietary modifications for enhanced cancer therapy
Kanarek, N., Petrova, B., & Sabatini, D. M. (2020) · Nature · doi:10.1038/s41586-020-2124-0 · Cited by 411
Metadata
- Authors
- Wilson, P. M., Danenberg, P. V., Johnston, P. G., Lenz, H.-J., & Ladner, R. D.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2014-04-15
- Volume
- 11
- Issue
- 5
- Pages
- 282-298
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2060311941
- Cited by
- 388
- References
- 134
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.